Two therapeutic targets identified for lung cancer
Salk scientists discover a pair of enzymes that drive non-small-cell lung cancer by promoting inflammation which could inform the development of new therapies.
List view / Grid view
Enzymes are macromolecular biological catalysts. Enzymes accelerate, or catalyse, chemical reactions.
Salk scientists discover a pair of enzymes that drive non-small-cell lung cancer by promoting inflammation which could inform the development of new therapies.
A new study has found a novel way to target an enzyme involved in cancer growth, which could inform therapeutics for the condition.
A new study may provide the basis for combating malignant leukemia stem cells.
A cellular pathway may reduce side effects and extend immunotherapy duration in patients with the most common form of liver cancer.
A research team have developed a new CRISPR platform called RESCUE (RNA Editing for Specific C to U Exchange).
Researchers have used machine learning to discover that the two most widespread DNA structures cause genome mutations that lead to cancer.
A study has shown that deactivating an enzyme linked to ceramides caused obese mice to improve their metabolic health, indicating a drug target.
A study has discovered that a biomarker associated with pancreatitis is involved in its development to pancreatic cancer.
Redundancies have been discovered in the biochemical signalling pathways of immune cells which could impact cancer immunotherapy.
Researchers have found an enzyme and its counterpart which inhibit T-cells from attacking tumour cells.
New research could lead to novel treatments for autoimmune disorders and sheds light on the causes of autoimmunity.
Columbia University discovery could be a major step in developing therapies for cancer, controlling cholesterol...
New approach restores epithelial function in diarrhoea and inflammatory bowel disease models...
Researchers in the US have discovered how a gene involved in regulating hormone receptors, GREB1, may contribute to drug resistance in some prostate cancer patients.
Series of molecules may provide more reliable relief with fewer side effects...